Psychoneuroendocrinology of posttraumatic stress disorder by Ruiz, Juliana Elena et al.
Psychoneuroendocrinology of posttraumatic
stress disorder
Psiconeuroendocrinologia do transtorno de
estresse pós-traumático
Abst rac t
Objective: To review the literature on neurobiological findings related to hypothalamic-pituitary-adrenal axis dysfunctions associated
with posttraumatic stress disorder. Method: The relevant scientific findings were described according to the date of publication
and the characteristics of the studies: preclinical studies, studies on early life violence as a risk factor, and clinical findings related
to patients diagnosed with posttraumatic stress disorder. Results: A rich literature on hypothalamic-pituitary-adrenal axis
dysfunctions and posttraumatic stress disorder was found. Neurobiological findings showed that posttraumatic stress disorder is
associated with hypothalamic-pituitary-adrenal axis dysfunctions and other brain-related structures: prefrontal cortex, hippocampus,
and amygdala. Posttraumatic stress disorder patients have low plasma levels of cortisol and present increased responsivity of
glucocorticoid receptors, suggesting that the inhibition of negative feedback plays a significant role in the disorder pathology.
Preclinical studies using animal models of maternal deprivation showed that depending on the moment the trauma occurred
during the development, different hypothalamic-pituitary-adrenal axis dysfunctions were produced. Clinical studies showed that
early life stress is related to the development of psychopathologies during adulthood. Conclusions: There is robust evidence of
hypothalamic-pituitary-adrenal axis dysfunctions related to posttraumatic stress disorder, and the mechanisms underlying this
association are being better understood.
Descriptors: Neuroendocrinology; Stress disorders, post-traumatic; Hydrocortisone; Hydrocortisone adrenocorticotropic hormone;
Corticotropin-releasing hormone
Resumo
Objetivo: Os autores realizaram uma revisão tradicional da literatura sobre os achados neurobiológicos das disfunções do eixo
hipotálamo-pituitária-adrenal associados ao transtorno de estresse pós-traumático. Método: Os achados científicos relevantes
foram descritos de acordo com a ordem cronológica de publicação e as características dos estudos, se eram pré-clínicos,
relacionados à violência precoce como fator de risco e, finalmente, achados clínicos em pacientes portadores de transtorno de
estresse pós-traumático. Resultados: Foi encontrada uma literatura rica de achados a respeito de disfunções do eixo hipotálamo-
pituitária-adrenal e transtorno de estresse pós-traumático. Os achados mostraram que o transtorno de estresse pós-traumático
está associado a disfunções deste eixo e de estruturas cerebrais como o córtex pré-frontal, hipocampo e amídala. Os pacientes
com transtorno de estresse pós-traumático apresentam um aumento da responsividade dos receptores de glicocorticóides, suge-
rindo que a inibição do feedback negativo tem um papel importante na fisiopatologia do quadro. Estudos pré-clínicos com
modelos animais de deprivação maternal evidenciaram que, dependendo de quando o trauma ocorre, a disfunção do eixo será
diferente. Os estudos clínicos mostram que o estresse precoce está relacionadas ao desenvolvimento de psicopatologia durante a
vida adulta. Conclusões: As disfunções do eixo hipotálamo-pituitária-adrenal relacionadas ao transtorno de estresse pós-trau-
mático são evidências robustas e os mecanismos subjacentes a ele são cada vez mais compreendidos.
Descritores: Neuroendocrinologia; Transtornos de estresse pós-traumático; Hidrocortisona; Hormônio adrenocorticotrófico;
Hormônio liberador de corticotropina
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Int roduct ion
The DSM-IV criterion A for posttraumatic stress disorder
(PTSD) requires the presence of a stressor event that threatened
the subject’s emotional or physical integrity creating horror or
despair.1
PTSD diagnosis has three clusters of symptoms: 1)
reexperience of the traumatic event, 2) avoidance and
numbness, and 3) hyperarousal.
Image revivals happen in the form of intrusive memories,
persistent reminiscences, and traumatic nightmares followed
by psychological distress and physiological reactivity. Avoidance
is the effort to avoid thoughts, feelings, activities or people
related to the trauma. Numbness could present as a decreased
interest in daily activities, feeling of detachment, and restricted
range of affect. The hyperarousal cluster is characterized by
symptoms of insomnia, irritability, difficulty in concentrating,
hyperarousal, and exaggerated startle response.
Studies on the hypothalamic-pituitary-adrenal axis (HPA) and
the autonomous nervous system (ANS) are critical since they
establ ish a re lat ionship between body/mind and the
environment. Thinking in a simplistic way, we would be
tempted to look for a hyperactivation of these systems, but
scientific findings show a different reality.
The prefrontal cortex, the hippocampus and the amygdala
are related to the HPA axis. The hippocampus and the prefrontal
cortex are mostly inhibitors, while the amygdala activates the
HPA.2 The HPA axis is highly sensitive to external changes,
which are the focus of PTSD studies. The response to
glucocorticoids (GC) could be initiated by direct activation of
paraventricular nucleus by nociceptive pathways (pain),3 innate
defensive responses (predators aversion)4 or multimodal sen-
sorial association (e.g. conditioned fear).5
These cerebral  st ructures are deeply re lated to the
hypothalamus, where the corticotrophin release hormone (CRH)
is produced by hypophysiotropic neurons at the medial
parvocellular nucleus of the paraventricular nucleus (PVN).
Many studies connected the hippocampus to the HPA axis.6
Hippocampal stimulation decreases corticosterone in rats and
cortisol in humans,7 suggesting that this region inhibits HPA
axis activation.
The prefrontal cortex is also implicated on stress regulation.
Anterior cingulate cortex and lesions of the prelimbic division
increase adrenocort icotropic hormone (ACTH) and
corticosterone secretion in rats and induce CRH production
by PVN after forced restraint,4 suggesting a specific stressor
role in the HPA axis inhibition.
It is supposed that the amygdala activates the HPA axis. Its
influence is highly mediated by central and medial amygdaloid
nucleus, representing the most important amygdala projection
to brain stem, hypothalamus, and midbrain.2 Amygdaloid
lesions reduce corticosterone or ACTH after stress, while
stimulation increases the HPA axis activation.2
Preclinical studies
Maternal deprivation models with rodents and variable
foraging demand in primates have shown that depending on
which development stage the stress occurred, different results
would be determined; it was called ’timing effects’,8 leading to
a hypo- or hyperactivation of the HPA axis during the animal
adulthood. These findings have shown that early life events
are powerful risk factors, and apparently if these events happen
during specific development periods such as adolescence the
subjects have a higher risk for PTSD.
At same time, other studies with enriched environment have
produced opposite findings regarding behavioral and hormonal
responses to stress. Branchi et al. have studied rats raised at
communitarian nests, a richer early social environment simi-
lar to the wild form of nests of many rodent species.9 They
have found that rats raised at these nests have more ability to
interact socially, and their acquisition of social behavior patterns
was faster, either for dominant or subordinate behavior, than
those rats raised isolated. The former has higher levels of
neuronal growth factors such as brain-derived neurotrophic
factor (BDNF) levels. The authors have concluded that a socially
rich environment is associated with better social life during
adulthood, and those are associated by a markedly change in
neurotrophins at selective brain areas like the hippocampus
and the hypothalamus.
Prolonged stress ends with an increased glucocorticoid and
catecholamine secret ion by the adrenal.  Prolonged
glucocorticoid exposure causes the destruction of the neurons
located at the CA3 region of the hippocampus, reducing glucose
and increasing calcium entries in these cells.10 Due to
increased glutamate and glucocorticoid levels, a greater calcium
mobilization is generated by N-methyl-D-aspartate (NMDA) and
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)
receptors activation and an activation of an intracellular system
of second messengers leading to a cellular cascade effects.
Cellular mechanisms try to recapture glutamate from synaptic
cleft or tamponate calcium ions to avoid free radicals
accumulation and cell death.
Gould et al. have demonstrated the deleterious effects of
glucocorticoid on neurogenesis.11 Neurogenesis reduction,
neurotoxicity, and impairment of the neuron ability to survive
seem to be responsible for the hippocampal atrophy described
in some patients with PTSD.12
New studies should figure out how this hippocampal atrophy
occur.  Some studies have suggested that many
neurotransmitters like serotonin, dopamine, and noradrenaline
play a role in this process. Also, low cortisol levels and high
CRH levels can contribute to the atrophy. The intricate
mechanisms of the organism reaction to violence could be
better known with the advance of preclinical studies.
Violence against children and teenagers
Among the risk factors for the development of PTSD during
adulthood, exposition to traumatic events, particularly during
childhood, has a significant role. Such predisposition could
vary according to frequency, intensity, and duration of past
traumatic events.13-16 However, it is unspecific, since it occurs
in other disorders like mood disorder, anxiety, substance abu-
se, and conduct and personality disorders.17
Breier et al. have recruited subjects with history of parental
separation and have found a high proportion of subjects with
psychiatric conditions.18 These subjects had higher cortisol
basal levels compared to controls. Heim et al. have conducted
many neuroendocrinological investigations looking for
correlations between early trauma, depression, and HPA axis
function.19-21 They have found that a trauma report, more than
a major depressive disorder diagnosis, led to HPA axis
dysfunction. Multiple regression analysis of these data has
revealed that traumatic history was related to stress hyperactivity,
and that the interaction between child abuse and trauma was
the greater predictor of responsivity to ACTH.
Carpenter et al. have studied the CRH on spinal fluid (CRH/
SF) concentration of 27 depressed, medication free individuals
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and 25 paired controls.22 The perceived stress levels during the
pre-school and pre-adolescence years have been verified with a
self-report scale. The difference between the means of CRH/SF
of patients and controls has not shown statistical significance.
However, a regression model has shown that the stress
perception was a powerful predictor of CRH/SF alteration, while
depression has not had this power. Perinatal adversity and pre-
adolescence years have been independently associated with
CRH concentration.
Maercker et al. have interviewed young adults from Dresden
regarding the occurrence of traumatic events, depressive, and
PTSD uprising symptoms.23 The sample was subdivided into
subjects with traumas during childhood (up to 12 years) and
subjects with traumas during adolescence (after 13 years). They
have found that a quarter of the sample reported a traumatic
event. Those who reported a traumatic event during childhood
had odds ratio (OR) of 5.18 to develop depression compared to
0.91 to develop PTSD. Those who reported a traumatic event
during adolescence had an OR of 0.19 to develop depression
compared to 1.10 to develop PTSD.
The initial clinical findings have confirmed that the presence
of early adversity, particularly during susceptible periods, is an
important risk factor for PTSD development during adulthood.
Clinical studies
The clinical studies with PTSD patients are providing the first
scientific evidence on HPA axis dysfunction. The first studies have
evaluated catecholamines and their relation with basal cortisol.
Lemieux et al. have evaluated norepinephrine, dopamine, and
cortisol on 24-hour urine from 28 women (11 with PTSD and
abuse during childhood, 8 with abuse during childhood without
present PTSD, and 8 women without abuse or PTSD).24 The
patients with PTSD had significantly higher norepinephrine,
dopamine, and cortisol levels, differently from other findings with
male veterans with PTSD. The authors have credited this difference
to the age of exposure to the traumatic experience.
Mason and Jacobs have found a higher norepinephrine/cortisol
ratio in PTSD patients; they have speculated that it happened due
to a norepinephrine increment and not a cortisol elevation.25-26
Studies with veterans have shown different findings compared
to studies with women. Boscarino et al. have found that veterans
with PTSD had lower cortisol levels, and these findings are
related to the presence of PTSD diagnosis.27 Veterans with a
past diagnosis of PTSD did not show this HPA dysfunction,
suggesting that the traumatic effect tends to disappear with time
and clinical improvement.
Yehuda et al., in a series of studies, have confirmed28-30 the
findings of Boscarino et al. They have found that the dysfunction
was related to specific traumas. The dysfunction was found when
the traumatic event occurred during combat operations, and not
in veterans who presented PTSD after they were back at home.
The same finding has been observed in Holocaust survivors with
PTSD compared to those without PTSD and normal controls, only
the formers had lower cortisol levels. Therefore, the authors have
affirmed that there are differences in the neurobiology of specific
traumas depending on the moment they affected the subject.
The low cortisol level is probably related to significant traumas
that lead to the development of PTSD, and it remains symptomatic.
Again, the productive group from New York,31 trying to further
investigate PTSD of the HPA axis dysfunction, has evaluated
cortisol and GC receptors after the dexamethasone suppression
test (DST) in 23 Holocaust survivors, 27 veterans, and 10 healthy
controls. They have found a higher cortisol and GC lymphocyte
receptor suppression in older trauma survivors with PTSD
compared to survivors without PTSD and controls. The
dexamethasone responses were not related to PTSD severity,
but to the number of years after the traumatic event and
the presence of PTSD symptoms.
Studying civilians, Young and Breslau have evaluated a
representative sample from the community (n = 1,200).32-33
This sample differed from patients who looked for specialized
services, an indicator of the severity of trauma and the
symptoms specificity. In this sample, 265 subjects had been
exposed to trauma and 68 had a present or past PTSD
diagnosis. The exposed group with PTSD had a higher
salivary cortisol level in the evening compared to the non-
exposed group. When comorbidity with major depressive
disorder (MDD) was analyzed, only the subjects with this
comorbidity had the increased cortisol level. People with
PTSD alone did not differ from controls regarding salivary
cortisol levels. These data suggest that, in these cases, the
PTSD was probably milder because the traumas were not
so violent (difference between violence and barbarity)
compared to those of Holocaust survivors or veterans, and
did not present the same HPA axis dysfunction, which
suggests that the PTSD diagnosis must be reformulated to
become less inclusive.
Using the same sample, they have analyzed urinary
catecholamines collected during two consecutive nights.
The group with PTSD diagnosis had significantly higher
levels of catecholamines compared to the exposed group
without PTSD diagnosis and the non-exposed group. Those
exposed to violence, but without PTSD diagnosis, had
significantly lower catecholamines levels compared to the
individuals from the other groups. The cortisol levels did
no t  d i f f e red  be tween the  g roups ;  when ana lyzed
regarding the comorbidity with depression, the group with
PTSD only did not differed from the group without PTSD
or MDD. Women with MDD and PTSD had significant
higher levels of cortisol. The authors have concluded
that trauma in itself did not lead to a sustained cortisol
or catecholamines elevation. PTSD is associated with
higher catecholamines levels, however, PTSD subjects
did not have urinary cortisol levels alterations. It is
possible that these data might be replicated with a specific
sample of civilians with PTSD diagnosis.
Rhoeleder has studied the GC receptor sensibility through
interleukin 6 (IL6) and alpha tumor necrosis factor (TNF-α)
concentrations after dexamethasone (DEX) ingestion in 12
refugees from Bosnia with PTSD and 13 controls.34 The
PTSD patients were non-responders in the morning and
the levels did not increase during the day. They needed a
lower DEX dose to suppress cytokines; the IL6 production
was significantly increased in patients, but not the TNF-α
production. The authors have concluded that refugees with
PTSD had hypocortisolism associated with higher sensitivity
of the immunological tissues to GC. The findings by Yehuda
et al. of an increased sensitivity to GC receptors in PTSD
patients started to be replicated by other groups.
Bremner et al. have studied 52 women with PTSD with
and without sexual abuse during childhood through a HPA
axis evaluation.35 Women with abuse history and PTSD
diagnosis had lower cortisol levels in the evening compared
to women without PTSD. The ACTH response to the CRF
challenge test was blunted compared to not abused women
(but not for those without abuse and PTSD). There were
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not differences between ACTH responses to CRF. High levels
of symptoms were associated with low levels of cortisol in
the evening. These findings lead to the conclusion that early
abuse is associated with CRF elevation, suggested by a
decrease in hypophysis sensitivity to CRF, as well as abuse
wi th PTSD was assoc ia ted wi th more pronounced
hypocortisolemia at noon.
Lindauer et al. have studied 24 Dutch policemen, 12 with
PTSD and 12 exposed to violence but who did not develop
PTSD.36 Among those with PTSD, 8 had been exposed to
interpersonal violence and four to accidents. Three of them
had overlapped depressive symptoms, with mild to major
depressive disorder after the PTSD onset, which was the main
diagnosis. Subjects with PTSD had a smaller hippocampal
volume on both sides. Subjects with PTSD had higher salivary
cortisol compared to controls. PTSD subjects presented more
perseverations and were prone to have more intrusions and
worse working memory. These findings showed an opposite
result: a specific group of subjects, police officers with PTSD,
had an increase in cortisol, which the authors linked to damage
to hippocampus and memory.
Gunnar et  a l .  have studied ser ia l  sal ivary cort isol
concentrations of 18 Rumanian orphans who stayed at an
institution for at least 8 months under very poor care conditions
compared to 15 orphans who were adopted earlier and stayed
for less than 4 months at the institution and 27 children raised
by their own families from British Columbia (Canada).37 Sali-
va samples were collected when the children had been adopted
for at least 6 years. Rumanian orphans had a lower cortisol
mean than the other both groups. There were no differences
between the groups with an earlier adoption and that of children
born in Canada. The longer the orphans remained
institutionalized, the more pronounced was the HPA axis
dysfunction, the lower their IQ and their height. The two last
factors, however, did not interfere with cortisol. This finding
showed that small children exposed to persistent and severe
violence have reduced cortisol levels.
Trying to further investigate hypocortisolemia, Yehuda et al.
have studied veterans with and without PTSD using the
Dexamethasone Suppression Test (DST) to evaluate a HPA axis
inhibition through an increased negative feedback.38 The
hypothesis came with findings of a hypersuppression of cortisol
production and a higher decrease in GC receptors on
lymphocytes after low dexamethasone dose administration to
veterans with and without PTSD.
The DST is used to evaluate the negative feedback of GC
receptors, particularly at the hypophysis level. The inhibition
by negative feedback is compatible with a series of findings:
1) high CRF levels at CSF; 2) blunted responses of ACTH to
CRF infusion; 3) ACTH increase to high metyrapone dose,
enough to suppress cortisol production; and 4) inhibition
through cortisol mediated negative feedback regardless if these
abnormalities happened with normal or low cortisol levels.
However, some studies have diverged from this trend showing
ACTH response increase to CRF in PTSD patients compared to
controls, and a higher ACTH response to a psychosocial
stressor.19,39 These findings associated with low cortisol plas-
ma levels lead to the alternative hypothesis that PTSD HPA
axis dysfunction was due to a subclinical adrenal insufficiency
or a low adrenal secretion.
As the cortisol negative feedback acts at many levels, the
increased inhibition by negative feedback through increase in
GC receptors sensitivity should decrease ACTH and cortisol at
comparable levels. According to this model, cortisol production
by adrenals was primarily dependent on ACTH secretion. The
alternative hypothesis should produce a higher ACTH/cortisol
ratio, particularly marked when CRF increases. Therefore, the
increased inhibition of negative feedback should not modify
the ACTH-cortisol ratio, whilst the low cortisol production by
the adrenal should increase the same ratio.
Yehuda et al. have tested the hypothesis evaluating the ACTH
concentrations and their relations with cortisol in response to
a low dexamethasone dose (0.5 mg).38 They have studied 29
men, and 9 women (19 with PTSD and without PTSD). They
have found a significant ACTH and cortisol reduction after
DEX in subjects with PTSD compared to those without PTSD.
These findings suggest that low cortisol levels after DEX are
not due to low cortisol production by the adrenal or low adrenal
sensitivity to ACTH. This study enhances the hypothesis of a
negative feedback increase induced by cortisol leading to an
ACTH production inhibition. PSTD is associated to ACTH
secretion inhibition by the hypophysis produced by increase
in the negative feedback induced by cortisol.
Although a great ACTH decrease after DEX has been found
in PTSD patients, this finding did not explain much about
central responsivity, since dexamethasone does not easily
penetrate the hematoencephalic barrier.40
Trying to evaluate the central responsivity, Yehuda et al.
have evaluated veterans with and without PTSD, who received
daily low doses (17.5 mg/day) of intravenous (iv) hydrocortisone
or placebo during two weeks.41 The PTSD patients had a greater
ACTH decrease reflecting a higher GR responsivity to cortisol.
In spite of the fact that cortisol has a better ability to trespass
the hematoencephalic barrier than dexamethasone does, it is
excreted from brain through steroids transporters such as P
glycoproteins. Even with a 2.5 increase in plasma cortisol
concentration after the hydrocortisone injection, we cannot
assert that it was enough to saturate the brain excretion pumps,
producing a central action. However, the low levels of ACTH
demonstrated increase responsivity to GC in PTSD, which might
reflect central alterations of GC.
Inslicht et al. have studied basal salivary cortisol levels in
49 women who were exposed to domestic violence (15 with
present PTSD, 14 with past PTSD, and 20 without PTSD).42 A
correlation between the time of trauma exposure and high
concentrations of salivary cortisol was found. The more recent
the trauma, the higher the cortisol level. The PTSD group
(past and present) had higher cortisol levels, even when the
data was controlled by drugs that affect the axis. The abused
group had more scores of depression on the HCL-90, but the
presence of depression did not correlate with neuroendocrine
findings. The same was true for the comparison between
women with a present depressive episode and those without a
depressive episode (using the SCID-I).
The study showed that women with lifetime PTSD have
increased cortisol levels. The sample results were obtained
from the community sample; people who did not spontaneously
looked for a mental health service. Similarly to the study by
Breslau et al., the data suggest that it is possible to find different
pathophysiology depending on specific trauma and population.
Santa Ana et al. have examined the HPA axis and subjective
stress regarding a physical stressor (hand immersion in cold
water) in 89 patients with PTSD.43 ACTH, cortisol, and
subjective stress were measured before and after the test.
Individuals were divided into controls (31), with PTSD due to
trauma during childhood (25), and PTSD due to trauma during
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adulthood (33). A consistent finding was that 48% from the
traumatized group were alcohol dependent.
Subjects with PTSD, regardless of the moment they suffered
the trauma, showed a less robust response to ACTH. Also, in
spite of the presence or absence of alcohol dependence, victims
of trauma during childhood had lower basal cortisol and lower
cortisol concentrations at all measures after the physical stress.
Patients with trauma during adulthood did not show a recovery
of cortisol levels up to 2 hours after the end of the test.
Otte et al., looking for alterations on mineralocorticoids
receptors (MR), have studied 11 patients with PTSD compared
to 11 controls. The subjects were treated with 4 g of metyrapone
(to inhibit cortisol production from the adrenal).44 On the next
day, they received 0.5 mg of fludrocortisone, a MR agonist or
placebo. ACTH, cortisol, and 11-deoxycortisol were evaluated
every 30 minutes from 2 am to 9 pm on blood samples.
Comparing placebo to fludrocortisone, the latter decreased
significantly ACTH and cortisol levels on both groups. Patients
with PTSD had higher cort isol and ACTH levels after
metyrapone, reinforcing the increased sensitivity of GR in PTSD
patients, but there were not differences with the use of MR
agonist, leading the authors to postulate that there are no
differences regarding MR in the HPA function of PTSD patients
and normal controls.
Griffin et al. have applied the DST (with low dose 0.5 mg)
on 70 women victims of violence and 14 controls without
trauma history or psychiatric diagnosis.45 Among the victims,
15 had PTSD, 27 PTSD associated with depression, and 8 did
not have PTSD or depression. The victims of violence with
PTSD, with or without depression, had lower cortisol levels
compared to the other groups. The victims of violence with
PTSD without depression had a higher dexamethasone
suppression compared to the healthy individuals and the group
with PTSD and depression. Again, the evidence of increased
GC receptors sensitivity hypothesis and the finding of low levels
of cortisol in victims with PTSD were reinforced.
Discuss ion
The scientific evidence of HPA axis responses of PTSD patients
suggests that susceptible individuals exposed to extreme
violence have a persistent reaction to the stressor. A great GR
responsivity leads to a decrease in ACTH and cortisol
production. The low cortisol level could be unable to “turn
off ” the LC-SNS system causing autonomic hyperactivation
(leading to an increment of catecholamines levels). The
increased CRF could be partially responsible for symptoms like
insomnia, irritability, difficult concentrating, hyperarousal, and
exaggerated startle response found in PTSD patients.
Imaging studies of PTSD patients showed consistent data of
a decreased hippocampus volume.36 This finding could be
partially related to a hyperactivity of the HPA system.46-47
Functional imaging studies show hyperactivation of the
amygdaloid nucleus and a blunted answer from the prefrontal
medial cortex and anterior cingulum gyrus.48
These findings are consistent with memory reverberation
(limbic and temporal hyperactivation) and the lack of experience
elaboration, carried out by prefrontal cortex, with neural network
distributed through the cortex, and creation of representation.
The memory reverberation remains, since it is often present
(persistent reminiscences) with concurrent somatic symptoms
(hyperarousal). The subject lives as if the trauma was going
to happen again at any minute, and he/she needs to make
any efforts to avoid it (avoidance).
There is not any elaboration of the traumatic experience. It
is not incorporated to the self. The individual with PTSD feels
unable to act in order to avoid the imaginary trauma, which
could happen at any time. He/she does not trust his/her ability
to act or decide.
The memory reverberation creates confusion between
imagination and reality. The individual loses the perception of
reality.49 The understanding of reality and the present time is
distorted by the perception and the action.49
To understand the reality, the individual needs a healthy
mental functioning. A dysfunction of this mechanism could
lead to  memor y  reve rbe ra t ion,  ideas  o f  d i sab i l i t y,
insufficiency, and anxiety.50 This psychopathology has a
pathophysiological correspondence.
We can formulate that the mental process for a susceptible
subject to become ill is caused by an intense traumatic
experience. This subject creates a persistent sensation of an
imaginary danger, and feels that it is real. The organism reacts
with a HPA axis hyperactivation. It is possible to raise the
hypothesis that due to the intensity of the experience (in a
susceptible subject due to an early life stress) the sensitivity of
the GC receptors increases, decreasing the ACTH and cortisol
production. The imminence of danger feelings leads to
sympathetic activation persistence, since the low plasma
cortisol level is unable to “turn it off”.
These hypotheses try to correlate scientific and clinical
data. New studies must be proposed to increase our
knowledge on the psychological consequences of violence
in human beings. Medicine and psychology must look for
new diagnostic methods and more effective treatments of
violence victims. The search for innovation will be more
effective if based on scientific evidence.
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